Issue link: http://osercommunicationsgroup.uberflip.com/i/709455
AN INDEPENDENT PUBLICATION NOT AFFILIATED WITH NACDS Lee M. Oser CEO and Editor-in-Chief Jules Denton Kim Forrester Delaney Oser Carlos Velasquez Associate Publishers Lorrie Baumann Editorial Director Jeanie Catron JoEllen Lowry Karrie Welborn Associate Editors Yasmine Brown Jonathan Schieffer Graphic Designers Caitlyn McGrath Sarah Glenn Heather Canale Customer Service Managers Stacy Davis Show Logistics & Distribution James Gennette Mark Romero Sarah Robinson Account Managers Enrico Cecchi European Sales Chain Drugstore Daily is published by Oser Communications Group ©2016 All rights reserved. Executive and editorial offices at: 1877 N. Kolb Road, Tucson, AZ 85715 520.721.1300/Fax: 520.721.6300 www.osercommunicationsgroup.com European offices located at Lungarno Benvenuto Cellini, 11, 50125 Florence, Italy C h a i n D r u g s t o r e D a i l y M o n d a y, A u g u s t 8 , 2 0 1 6 4 MENTHOLATUM ANNOUNCES NO MESS VAPORIZING RUB WITH ROLL ON APPLICATOR The Mentholatum Company is announc- ing its new Mentholatum ® No Mess Vaporizing Rub with Roll On Applicator for the 2016-17 cough and cold season. The innovative rollerball applicator, which was developed in direct response to consumer feedback over chest rub messiness, is a continuation of the com- pany's proud tradition of providing American families with safe and effec- tive cough and cold remedies while meet- ing consumers' growing desire for con- venience. Consumer research indicates the roll on applicator offers a solution to the No. 1 complaint with chest rubs: the greasi- ness and messiness moms and children experience while using the product. Mentholatum No Mess Vaporizing Rub uses Mentholatum's innovative, maxi- mum strength formula – featuring 100 percent natural active ingredients – and a unique rollerball delivery system that ensures a smooth, mess-free application. It's the only chest rub on the market that combines this convenience with maxi- mum strength cough relief and natural active ingredi- ents. "There are 39 million moms with children under the age of 12 in the U.S.," said Angela Ho, Mentholatum US Marketing Director for Heritage and Pain Relief products. "A child with a cough or cold is one of the most common challenges that moms face today; however, lack of innovation and competitors' focus on other products has left many of these moms unsatisfied. ACURA: TAMPER-RESISTANT PRODUCTS COMBAT MEDICATION ABUSE Acura Pharmaceuticals, Inc. focuses solely on developing and commercializ- ing tamper-resistant products to combat medication abuse and misuse. For nearly a decade, Acura has been on the forefront of developing solutions to address this epidemic, with products using the com- pany's proprietary abuse deterrent Aversion ® , Impede ® and LIMITx™ Technologies. Exemplifying this approach is Nexafed ® (pseudoephedrine HCl, or PSE), with methamphetamine-deterring Impede, a technology also being used by a major consumer products company under license by Acura. It delivers the same relief profile that pharmacists and patients expect from traditional immedi- ate-release PSE products such as Sudafed tablets. PSE is the decongestant of choice in many cold medications, but it is com- monly used in the illegal production of meth. Nexafed's IMPEDE technology significantly disrupts the conversion of PSE to meth, making it virtual- ly useless for meth manufac- turing. More and more retailers are seeing the positive impact Nexafed has on communities that adopt it as their exclusive immediate release pseu- doephedrine product. Pharmacists under- stand that offering older products without meth-deterring technology means they may inadvertently be contributing to the meth production problem. Nexafed is once again the "No. 1 Pharmacist Recommended Brand" of abuse deterrent C o ntinued o n P age 8 5 C o ntinued o n P age 8 5